Developer docs
API playgroundTry for free, no card

Search company profiles

Hope in Focus

Full company profile

uuid02lqcbe

Namestring
Hope in Focus
Legal namestring
Hope in Focus
Websiteurl
hopeinfocus.org
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Hope in Focus is a 501(c)(3) patient advocacy nonprofit (EIN 46-4552134) headquartered in Ledyard, Connecticut, that supports individuals and families affected by Leber congenital amaurosis (LCA) and other rare inherited retinal diseases (IRDs). Founded in 2014 by Laura Manfre and Charles Priebe under the name Sofia Sees Hope and rebranded to Hope in Focus in 2025, the organization delivers a unified portfolio of community, education, and research-funding programs rather than a technology product. Core programs include the biennial LCA Family Conference, a podcast, webinars and video content, an e-newsletter, the Family Connections program, the Ambassador peer-support program, a patient registry, genetic testing resources, and clinical trial information.

The underlying "technology" is a content and community platform: a website (hopeinfocus.org), a podcast on SoundCloud, social channels, and structured educational assets covering 27+ LCA-causing genetic mutations and the LCA Therapy Development Pipeline. Revenue mechanics come entirely from donations and event income: individual donations, the annual Dinner in the Dark fundraiser at Foxwoods Resort Casino (with tiered tickets at $175 per person and a 20/20 Vision Patron Table at $2,020), corporate sponsorships (Opus Genetics, Atsena Therapeutics, Simply Majestic, Drink Caffeine, Genentech), and grants (e.g., the $5,000 Amgen RAREis Global Advocate Grant in September 2024). Strategic partnerships with gene therapy developers (Opus Genetics, Atsena, MeiraGTx, Sepul Bio, Odylia) and rare-disease organizations (Foundation Fighting Blindness, NORD, Global Genes) position the organization as the connective tissue between LCA patients and the clinical development pipeline.

Go-to-market is community-led: Hope in Focus reaches newly diagnosed families through ambassadors and the Family Connections program, retains them through recurring touchpoints (podcast, newsletter, webinars), and convenes the broader ecosystem at the LCA Family Conference, which drew 135 attendees in Minneapolis in 2025. The organization has raised $2.5M+ cumulatively since founding and claims reach across 32+ countries, operating with a small staff of 1–10 led by Executive Director Courtney Coates (promoted June 2025) and Board Chair Laura Manfre.

Short descriptiontext

Hope in Focus is a 501(c)(3) patient advocacy nonprofit that supports individuals and families affected by Leber congenital amaurosis and rare inherited retinal diseases through education, community programs, and research fundraising, serving patients across 32+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLedyard, United States
HQ citystring
Ledyard
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
patient advocacy services, inherited retinal diseases, rare disease nonprofit, community education programs, retinal research funding
Industry3 codes
PRIMARYBPAGACAM
Rare Disease & Special Needs Support Organizations
SECONDARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
SECONDARYBPAGACAD
Mental Health & Crisis Support Services
NAICS code2 codes
  • Other Individual and Family Services624190
  • Child and Youth Services62411
SIC code2 codes
  • Services-Social Services8300
  • Services-Membership Organizations8600
Product category
Patient Advocacy / Rare Disease Nonprofits
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Individual Donations
TypeGrants Donations
Description

Individual donors contribute directly to support research and community programs. The organization accepts donations through its website and various fundraising initiatives.

hopeinfocus.org
2Signature Fundraising Events
TypeGrants Donations
Description

Annual Dinner in the Dark events at Foxwoods Resort Casino generate significant revenue. The 2025 event raised over $190,000 with 260 attendees. The 2024 event raised over $225,000 with 330 attendees.

old.hopeinfocus.org
3Corporate Sponsorships
TypeGrants Donations
Description

Corporate sponsors including Opus Genetics, Atsena Therapeutics, Simply Majestic, Drink Caffeine, and others provide financial support and sponsorship for events and programs.

hopeinfocus.org
4Grants
TypeGrants Donations
Description

Hope in Focus receives grants such as the $5,000 RAREis Global Advocate Grant from Amgen in September 2024.

hopeinfocus.org
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Marketing or Sales, Operations, Others
Pricing details3 tiers
1Individual tickets for Dinner in the Dark event
ModelOtherBilling cadenceOne-time
Notes

$175 per person for the annual Dinner in the Dark fundraising event at Foxwoods Resort Casino

old.hopeinfocus.org
2Patron table sponsorship
ModelOtherBilling cadenceOne-time
Notes

20/20 Vision Patron Table: $2,020 for a table of 8 guests with preferred seating

old.hopeinfocus.org
3Event sponsorships
ModelOtherBilling cadenceOne-time
Notes

Sponsorship opportunities begin at $500

old.hopeinfocus.org
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Hope in Focus is a nonprofit patient advocacy organization that supports individuals and families affected by Leber congenital amaurosis (LCA) and other rare inherited retinal diseases through education, peer-support programs, and fundraising for research. Its core offerings include the LCA Family Conference, podcast, newsletter, videos and webinars, a Family Connections program, an Ambassador peer-support network, and resources on genetic testing, the LCA therapy development pipeline, clinical trial information, and a patient registry. The organization funds its mission through individual donations, corporate sponsorships, grants, and signature fundraisers such as Dinner in the Dark.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Supported LCA community since 2014 with education, resources, and connections
+1 more record
Product overview1 text field

Hope in Focus is a nonprofit patient advocacy organization offering a unified portfolio of community support, education, and awareness programs rather than a technology product suite. The core offerings include the LCA Family Conference (annual gathering), Podcast, Newsletter, Videos & Webinars, Family Connections Program, Ambassador Program, and resources covering LCA therapy development, patient registry, genetic testing, clinical trials, and community stories. Fundraising events include Dinner in the Dark and Party for Sight. These programs work together to connect the LCA community, advance research awareness, and support families throughout their journey.

Product and service2 records
1LCA Family Conference
CategoryCommunity Education & Events
Description

Annual/biennial educational conference bringing together families affected by LCA, researchers, clinicians, and advocates to exchange knowledge, share experiences, and strengthen the global LCA/IRD community. Aimed at LCA patients, families, clinicians, and researchers.

2Dinner in the Dark
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-07-07
Description

Opus Genetics is a Hope in Focus partner developing OPGx-LCA5 gene therapy for LCA5. The company reached FDA alignment for Phase 3 clinical trial design. Hope in Focus provides patient advocacy support and helps connect patients with clinical trial opportunities.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Foundation Fighting Blindness is a key partner providing research updates, clinical trial information, and collaboration on patient advocacy. They hosted the Retinal Therapeutics Innovation Summit and partner on the LCA Family Conference.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Sepul Bio is a partner developing antisense oligonucleotide therapies for LCA10 and USH2A. Hope in Focus provides patient input for clinical development programs. Sepul Bio sponsors the LCA Family Conference.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

MeiraGTx is a partner developing gene therapies including treatments for LCA4 and XLRP. They sponsor the LCA Family Conference and are advancing treatments toward FDA approval.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Odylia Therapeutics is a nonprofit developing gene therapies for rare diseases including LCA6 (RPGRIP1). The organization was featured on the Hope in Focus podcast and is advancing toward clinical trials.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

NORD is a rare disease organization affiliated with Hope in Focus, providing additional resources and advocacy support for the rare disease community.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Global Genes is a rare disease advocacy organization partnered with Hope in Focus to support the IRD community.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

A rare disease advocacy nonprofit that partners directly with Hope in Focus. It is comparable because it serves as a broader umbrella for rare disease communities with similar education, advocacy, and patient-support programming aimed at underserved disease populations.

2Retina International
TypeRegional player
Description

An umbrella patient advocacy organization for inherited retinal diseases operating primarily in Europe and globally. It is comparable as an IRD-focused advocacy, education, and research-funding peer but with a transatlantic/European center of gravity rather than US-based like Hope in Focus.

TypeBroad incumbent
Description

The largest US rare disease umbrella organization, affiliated with Hope in Focus and offering grants, advocacy, and patient resources. It is comparable as a cross-disease nonprofit serving the same patient-advocacy and research-funding functions but at a much broader and more institutionalized scale.

TypeDirect peer
Description

A nonprofit funding vision-loss research and supporting early-career ophthalmology researchers. It is comparable because it channels donor dollars into eye research and patient impact — including IRD-adjacent work — sharing overlapping donor audiences with Hope in Focus.

TypeDirect peer
Description

The largest US nonprofit focused on inherited retinal diseases, funding research and advocating for treatments. It is the most directly comparable peer because it overlaps with Hope in Focus on LCA/IRD patient education, research funding, and co-hosted events like the LCA Family Conference.

TypeBroad incumbent
Description

An established US nonprofit focused on eye health and vision loss prevention across many conditions. It is comparable because it funds vision research, advocates for patients, and delivers public education — but at a broader ophthalmic scale that includes, but is not specific to, inherited retinal diseases.

7American Foundation for the Blind
TypeBroad incumbent
Description

A long-established national nonprofit advocating for people with vision loss across all causes. It is comparable as an advocacy and resource provider for visually impaired individuals but operates at a much broader, less gene-specific level than Hope in Focus.

TypeDirect peer
Description

A small disease-specific nonprofit focused on CRB1-related retinal disease, supporting research, families, and clinical trial recruitment. It is comparable because it operates an essentially identical model to Hope in Focus (single-gene LCA/IRD focus, family conferences, research funding) for a different mutation, representing the most direct substitute peer.

TypeDirect peer
Description

A disease-specific patient advocacy and research funding nonprofit for choroideremia, an inherited retinal disease. It is comparable because it mirrors Hope in Focus's gene-specific community, research funding, and clinical-trial-recruitment model within the same IRD therapeutic category.

10RD-CURE (RD-Cure Consortium / RDH12 Foundation)
TypeEmerging player
Description

A small disease-specific patient advocacy and research organization focused on RDH12-related retinal disease. It is comparable because it operates the same single-gene LCA/IRD advocacy and research-funding playbook as Hope in Focus and represents an emerging peer with potential to scale along similar lines.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hope in Focus

Patient Advocacy / Rare Disease Nonprofitshopeinfocus.org

Hope in Focus is a 501(c)(3) patient advocacy nonprofit that supports individuals and families affected by Leber congenital amaurosis and rare inherited retinal diseases through education, community programs, and research fundraising, serving patients across 32+ countries.

What Hope in Focus does

Hope in Focus is a 501(c)(3) patient advocacy nonprofit (EIN 46-4552134) headquartered in Ledyard, Connecticut, that supports individuals and families affected by Leber congenital amaurosis (LCA) and other rare inherited retinal diseases (IRDs). Founded in 2014 by Laura Manfre and Charles Priebe under the name Sofia Sees Hope and rebranded to Hope in Focus in 2025, the organization delivers a unified portfolio of community, education, and research-funding programs rather than a technology product. Core programs include the biennial LCA Family Conference, a podcast, webinars and video content, an e-newsletter, the Family Connections program, the Ambassador peer-support program, a patient registry, genetic testing resources, and clinical trial information.

The underlying "technology" is a content and community platform: a website (hopeinfocus.org), a podcast on SoundCloud, social channels, and structured educational assets covering 27+ LCA-causing genetic mutations and the LCA Therapy Development Pipeline. Revenue mechanics come entirely from donations and event income: individual donations, the annual Dinner in the Dark fundraiser at Foxwoods Resort Casino (with tiered tickets at $175 per person and a 20/20 Vision Patron Table at $2,020), corporate sponsorships (Opus Genetics, Atsena Therapeutics, Simply Majestic, Drink Caffeine, Genentech), and grants (e.g., the $5,000 Amgen RAREis Global Advocate Grant in September 2024). Strategic partnerships with gene therapy developers (Opus Genetics, Atsena, MeiraGTx, Sepul Bio, Odylia) and rare-disease organizations (Foundation Fighting Blindness, NORD, Global Genes) position the organization as the connective tissue between LCA patients and the clinical development pipeline.

Go-to-market is community-led: Hope in Focus reaches newly diagnosed families through ambassadors and the Family Connections program, retains them through recurring touchpoints (podcast, newsletter, webinars), and convenes the broader ecosystem at the LCA Family Conference, which drew 135 attendees in Minneapolis in 2025. The organization has raised $2.5M+ cumulatively since founding and claims reach across 32+ countries, operating with a small staff of 1–10 led by Executive Director Courtney Coates (promoted June 2025) and Board Chair Laura Manfre.

Hope in Focus firmographics

Firmographics
Name
Hope in Focus
Legal name
Hope in Focus
Website
https://hopeinfocus.org
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
1–10 employees
Short description
Hope in Focus is a 501(c)(3) patient advocacy nonprofit that supports individuals and families affected by Leber congenital amaurosis and rare inherited retinal diseases through education, community programs, and research fundraising, serving patients across 32+ countries.
Ownership category
akta.pro rank

Hope in Focus industry classification

Industry
Product category
Patient Advocacy / Rare Disease Nonprofits
NAICS
Other Individual and Family Services (624190), Child and Youth Services (62411)
SIC
Services-Social Services (8300), Services-Membership Organizations (8600)
akta.pro industry
PRIMARYBPAGACAM
Rare Disease & Special Needs Support Organizations
SECONDARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
SECONDARYBPAGACAD
Mental Health & Crisis Support Services

Keywords

  • Patient advocacy services
  • Inherited retinal diseases
  • Rare disease nonprofit
  • Community education programs
  • Retinal research funding

Where Hope in Focus is headquartered

Location

Headquarters

HQ city
Ledyard
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Hope in Focus business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Marketing or Sales, Operations, Others

Revenue model

  1. Individual Donations: Individual donors contribute directly to support research and community programs. The organization accepts donations through its website and various fundraising initiatives.
  2. Signature Fundraising Events: Annual Dinner in the Dark events at Foxwoods Resort Casino generate significant revenue. The 2025 event raised over $190,000 with 260 attendees. The 2024 event raised over $225,000 with 330 attendees.
  3. Corporate Sponsorships: Corporate sponsors including Opus Genetics, Atsena Therapeutics, Simply Majestic, Drink Caffeine, and others provide financial support and sponsorship for events and programs.
  4. Grants: Hope in Focus receives grants such as the $5,000 RAREis Global Advocate Grant from Amgen in September 2024.

Pricing tiers

ModelBillingPrice
OtherOne-timeIndividual tickets for Dinner in the Dark event
OtherOne-timePatron table sponsorship
OtherOne-timeEvent sponsorships

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Hope in Focus product offering

Product offering

Core offering

Hope in Focus is a nonprofit patient advocacy organization that supports individuals and families affected by Leber congenital amaurosis (LCA) and other rare inherited retinal diseases through education, peer-support programs, and fundraising for research. Its core offerings include the LCA Family Conference, podcast, newsletter, videos and webinars, a Family Connections program, an Ambassador peer-support network, and resources on genetic testing, the LCA therapy development pipeline, clinical trial information, and a patient registry. The organization funds its mission through individual donations, corporate sponsorships, grants, and signature fundraisers such as Dinner in the Dark.

Product overview

Hope in Focus is a nonprofit patient advocacy organization offering a unified portfolio of community support, education, and awareness programs rather than a technology product suite. The core offerings include the LCA Family Conference (annual gathering), Podcast, Newsletter, Videos & Webinars, Family Connections Program, Ambassador Program, and resources covering LCA therapy development, patient registry, genetic testing, clinical trials, and community stories. Fundraising events include Dinner in the Dark and Party for Sight. These programs work together to connect the LCA community, advance research awareness, and support families throughout their journey.

Differentiator

Problem solved

Functional benefit

Products and services

  • LCA Family Conference Annual/biennial educational conference bringing together families affected by LCA, researchers, clinicians, and advocates to exchange knowledge, share experiences, and strengthen the global LCA/IRD community. Aimed at LCA patients, families, clinicians, and researchers.
  • Dinner in the Dark

Quantifiable outcome

  • Supported LCA community since 2014 with education, resources, and connections
  • +1 more outcomes

Companies that use Hope in Focus

Customer profile

Named customers4 records

Segments1 record

Ideal customer profiles3 records

Hope in Focus technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Hope in Focus partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and major.

  • Opus GeneticscoreStrategic or Co-development Partner · 7 July 2026Opus Genetics is a Hope in Focus partner developing OPGx-LCA5 gene therapy for LCA5. The company reached FDA alignment for Phase 3 clinical trial design. Hope in Focus provides patient advocacy support and helps connect patients with clinical trial opportunities.
  • Foundation Fighting BlindnesscoreStrategic or Co-development PartnerFoundation Fighting Blindness is a key partner providing research updates, clinical trial information, and collaboration on patient advocacy. They hosted the Retinal Therapeutics Innovation Summit and partner on the LCA Family Conference.
  • Sepul BiocoreStrategic or Co-development PartnerSepul Bio is a partner developing antisense oligonucleotide therapies for LCA10 and USH2A. Hope in Focus provides patient input for clinical development programs. Sepul Bio sponsors the LCA Family Conference.
  • MeiraGTxcoreStrategic or Co-development PartnerMeiraGTx is a partner developing gene therapies including treatments for LCA4 and XLRP. They sponsor the LCA Family Conference and are advancing treatments toward FDA approval.
  • Odylia TherapeuticscoreStrategic or Co-development PartnerOdylia Therapeutics is a nonprofit developing gene therapies for rare diseases including LCA6 (RPGRIP1). The organization was featured on the Hope in Focus podcast and is advancing toward clinical trials.
  • National Organization for Rare Disorders (NORD)majorStrategic or Co-development PartnerNORD is a rare disease organization affiliated with Hope in Focus, providing additional resources and advocacy support for the rare disease community.
  • Global GenesmajorStrategic or Co-development PartnerGlobal Genes is a rare disease advocacy organization partnered with Hope in Focus to support the IRD community.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Hope in Focus competitors and assessment

Company assessment

Direct peers

  • Global Genes: A rare disease advocacy nonprofit that partners directly with Hope in Focus. It is comparable because it serves as a broader umbrella for rare disease communities with similar education, advocacy, and patient-support programming aimed at underserved disease populations.
  • Fight for Sight: A nonprofit funding vision-loss research and supporting early-career ophthalmology researchers. It is comparable because it channels donor dollars into eye research and patient impact — including IRD-adjacent work — sharing overlapping donor audiences with Hope in Focus.
  • Foundation Fighting Blindness: The largest US nonprofit focused on inherited retinal diseases, funding research and advocating for treatments. It is the most directly comparable peer because it overlaps with Hope in Focus on LCA/IRD patient education, research funding, and co-hosted events like the LCA Family Conference.
  • Curing Retinal Blindness Foundation: A small disease-specific nonprofit focused on CRB1-related retinal disease, supporting research, families, and clinical trial recruitment. It is comparable because it operates an essentially identical model to Hope in Focus (single-gene LCA/IRD focus, family conferences, research funding) for a different mutation, representing the most direct substitute peer.
  • Choroideremia Research Foundation: A disease-specific patient advocacy and research funding nonprofit for choroideremia, an inherited retinal disease. It is comparable because it mirrors Hope in Focus's gene-specific community, research funding, and clinical-trial-recruitment model within the same IRD therapeutic category.

Regional players

  • Retina International: An umbrella patient advocacy organization for inherited retinal diseases operating primarily in Europe and globally. It is comparable as an IRD-focused advocacy, education, and research-funding peer but with a transatlantic/European center of gravity rather than US-based like Hope in Focus.

Broad incumbents

  • National Organization for Rare Disorders (NORD): The largest US rare disease umbrella organization, affiliated with Hope in Focus and offering grants, advocacy, and patient resources. It is comparable as a cross-disease nonprofit serving the same patient-advocacy and research-funding functions but at a much broader and more institutionalized scale.
  • Prevent Blindness: An established US nonprofit focused on eye health and vision loss prevention across many conditions. It is comparable because it funds vision research, advocates for patients, and delivers public education — but at a broader ophthalmic scale that includes, but is not specific to, inherited retinal diseases.
  • American Foundation for the Blind: A long-established national nonprofit advocating for people with vision loss across all causes. It is comparable as an advocacy and resource provider for visually impaired individuals but operates at a much broader, less gene-specific level than Hope in Focus.

Emerging players

  • RD-CURE (RD-Cure Consortium / RDH12 Foundation): A small disease-specific patient advocacy and research organization focused on RDH12-related retinal disease. It is comparable because it operates the same single-gene LCA/IRD advocacy and research-funding playbook as Hope in Focus and represents an emerging peer with potential to scale along similar lines.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Hope in Focus social profiles

Digital presence

Hope in Focus compliance and trust

Trust signal

Compliance5 records

Hope in Focus financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hope in Focus leadership team

Management profile

Number of profiles

Profiles4 records

Hope in Focus funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hope in Focus M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hope in Focus

What does Hope in Focus do?

Hope in Focus is a nonprofit patient advocacy organization that supports individuals and families affected by Leber congenital amaurosis (LCA) and other rare inherited retinal diseases through education, peer-support programs, and fundraising for research. Its core offerings include the LCA Family Conference, podcast, newsletter, videos and webinars, a Family Connections program, an Ambassador peer-support network, and resources on genetic testing, the LCA therapy development pipeline, clinical trial information, and a patient registry. The organization funds its mission through individual donations, corporate sponsorships, grants, and signature fundraisers such as Dinner in the Dark.

Is Hope in Focus a public or private company?

Hope in Focus is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Hope in Focus founded?

Hope in Focus was founded in 2014. It employs 1 to 10 people.

Where is Hope in Focus based?

Hope in Focus is headquartered in Ledyard, United States, in the North America region.

How does Hope in Focus make money?

Four revenue lines are on record. Individual Donations are the primary driver. The others are signature Fundraising Events, corporate Sponsorships and grants.

Who are Hope in Focus's main competitors?

Direct peers on record are Global Genes, Fight for Sight, Foundation Fighting Blindness, Curing Retinal Blindness Foundation and Choroideremia Research Foundation. Retina International is listed as a regional player. Broad incumbents are National Organization for Rare Disorders (NORD), Prevent Blindness and American Foundation for the Blind. RD-CURE (RD-Cure Consortium / RDH12 Foundation) is listed as an emerging player.

Does Hope in Focus have an API?

No public API is recorded for Hope in Focus.

What industry is Hope in Focus in?

Hope in Focus's product category is Patient Advocacy / Rare Disease Nonprofits. Its primary akta.pro industry code is BPAGACAM, Rare Disease & Special Needs Support Organizations, with a secondary code of BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS). Its NAICS code is 624190 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales